These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 25373627)

  • 1. Methamphetamine psychosis: epidemiology and management.
    Glasner-Edwards S; Mooney LJ
    CNS Drugs; 2014 Dec; 28(12):1115-26. PubMed ID: 25373627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
    McKetin R; Lubman DI; Baker AL; Dawe S; Ali RL
    JAMA Psychiatry; 2013 Mar; 70(3):319-24. PubMed ID: 23303471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature.
    Grelotti DJ; Kanayama G; Pope HG
    Am J Psychiatry; 2010 Jan; 167(1):17-23. PubMed ID: 20068123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
    McKetin R; Baker AL; Dawe S; Voce A; Lubman DI
    Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis.
    Chen CK; Lin SK; Sham PC; Ball D; Loh EW; Hsiao CC; Chiang YL; Ree SC; Lee CH; Murray RM
    Psychol Med; 2003 Nov; 33(8):1407-14. PubMed ID: 14672249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia.
    Sulaiman AH; Said MA; Habil MH; Rashid R; Siddiq A; Guan NC; Midin M; Nik Jaafar NR; Sidi H; Das S
    Compr Psychiatry; 2014 Jan; 55 Suppl 1():S89-94. PubMed ID: 23433219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders.
    Temmingh HS; van den Brink W; Howells F; Sibeko G; Stein DJ
    J Dual Diagn; 2020; 16(2):208-217. PubMed ID: 31984872
    [No Abstract]   [Full Text] [Related]  

  • 8. Hostility among methamphetamine users experiencing psychotic symptoms.
    McKetin R; McLaren J; Lubman DI; Hides L
    Am J Addict; 2008; 17(3):235-40. PubMed ID: 18464001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users.
    Lapworth K; Dawe S; Davis P; Kavanagh D; Young R; Saunders J
    Addict Behav; 2009 Apr; 34(4):380-5. PubMed ID: 19097704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of psychotic symptoms among methamphetamine users.
    McKetin R; McLaren J; Lubman DI; Hides L
    Addiction; 2006 Oct; 101(10):1473-8. PubMed ID: 16968349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of risk factors for methamphetamine-associated psychosis.
    Arunogiri S; Foulds JA; McKetin R; Lubman DI
    Aust N Z J Psychiatry; 2018 Jun; 52(6):514-529. PubMed ID: 29338289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary evidence of behavioral predictors of recurrent drug-induced psychosis in methamphetamine abuse.
    Salo R; Nordahl TE; Leamon MH; Natsuaki Y; Moore CD; Waters C; Carter CS
    Psychiatry Res; 2008 Jan; 157(1-3):273-7. PubMed ID: 17928066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotic symptoms in methamphetamine psychotic in-patients.
    Srisurapanont M; Ali R; Marsden J; Sunga A; Wada K; Monteiro M
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):347-52. PubMed ID: 14604449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report.
    Tucker MG; Kekulawala S; Kent M; Mostafa S; Harvey R
    J Med Case Rep; 2016 Sep; 10(1):242. PubMed ID: 27599617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].
    Härtel-Petri R; Rodler R; Schmeisser U; Steinmann J; Wolfersdorf M
    Psychiatr Prax; 2005 Jan; 32(1):13-7. PubMed ID: 15633070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine-associated psychosis.
    Grant KM; LeVan TD; Wells SM; Li M; Stoltenberg SF; Gendelman HE; Carlo G; Bevins RA
    J Neuroimmune Pharmacol; 2012 Mar; 7(1):113-39. PubMed ID: 21728034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine.
    McKetin R; Hides L; Kavanagh DJ; Saunders JB; Dawe S
    Schizophr Res; 2018 Sep; 199():456-457. PubMed ID: 29680188
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there a discrete negative symptom syndrome in people who use methamphetamine?
    Voce A; Burns R; Castle D; Calabria B; McKetin R
    Compr Psychiatry; 2019 Aug; 93():27-32. PubMed ID: 31301605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twelve-month course and outcome of methamphetamine-induced psychosis compared with first episode primary psychotic disorders.
    Hajebi A; Amini H; Kashani L; Sharifi V
    Early Interv Psychiatry; 2018 Oct; 12(5):928-934. PubMed ID: 27991722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis.
    Yang M; Yang C; Liu T; London ED
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):31-37. PubMed ID: 31609149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.